These drugs fall within two categories: human GLP-1 backbone agents (that is, albiglutide, dulaglutide, liraglutide and semaglutide) and exendin-4 backbone agents (that is, exenatide, lixisenatide and tirzepatidethe latter activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors) 1
Her team analyzed hundreds of Reddit posts from 2020 through last August and identified frequent mentions of drug reactions and user errors, such as patients not knowing how to correctly dose and inject the medication
The effect is subtle, but for people struggling with nausea and bloating , it can make a meaningful difference in comfort
However, GLP-1 RAs may also confer neuroprotective benefits to the retina
"And that is, when you stop the microdosing, you will gain the weight back." That is also often the case when patients stop taking full doses of GLP-1 drugs